Tokyo, July 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062086) titled 'Establishment of a Novel Secondary Fracture Prevention Framework Using a Medication Adherence Prediction Scoring System' on July 1.
Study Type:
Observational
Primary Sponsor:
Institute - Hmamatsu University School of Medicine
Condition:
Condition - Femur Fracture
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to identify the factors influencing medication adherence for each specific drug.
In addition to patient background information, we will also investigate biological and functional factors that determine treatment adherence using saliva-derived biomarkers and body composition assessments (InBody).
Based on the identified factors, we will develop a drug-specific medication adherence prediction scoring system for use in drug selection.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with femoral fractures
Individuals who provided consent to participate in this study by signing a consent form
Aged 18 years or older
Key exclusion criteria - 1.Individuals from whom written consent could not be obtained (for retrospective medical record reviews, this includes cases where the subject or their representative refused to allow the use of their information for research purposes)
2.Other patients deemed inappropriate by the attending physician
Target Size - 300
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 07 Month 01 Day
Anticipated trial start date - 2026 Year 07 Month 01 Day
Last follow-up date - 2031 Year 07 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071036
Disclaimer: Curated by HT Syndication.
